Olanzapine transdermal patch (Starton Therapeutics)

奥氮平透皮贴剂 (Starton Therapeutics)

Report date: 2025/05/23 16:52:42

Base Information

Drug NameOlanzapine transdermal patch (Starton Therapeutics)
Drug Alias NameCMIO-OLANZCHEMIO OLANZCMIO-OLNZSTAR-OLZ
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor antagonistsSerotonin 2 (5-HT2) receptor antagonistsDopamine D2 receptor antagonists
TargetsDopamine D1 receptorSerotonin 2 (5-HT2) receptorDopamine D2 receptor
Therapy Area/IndicationsVomitingNausea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesStarton Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesStarton Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsVomitingNausea
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A